We are live on ! Find out more
GHDX

Genomic Health, Inc.
GHDX

Delisted

GHDX was delisted on the 7th of November, 2019.

Back to rankings

0 hedge funds and large institutions have $0 invested in Genomic Health, Inc. in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 219 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 221 → 0 (-221)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $2.44B → $0 (-$2.44B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 219

Holders
–
Holders Change
-221
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
219
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$627M
2
BlackRock
BlackRock
New York
-$276M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$187M
4
Renaissance Technologies
Renaissance Technologies
New York
-$170M
5
State Street
State Street
Massachusetts
-$98.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
51
D.E. Shaw & Co
New York
– -$4.85M -71,478 Closed
Rafferty Asset Management
52
Rafferty Asset Management
New York
– -$4.82M -71,084 Closed
AllianceBernstein
53
AllianceBernstein
Tennessee
– -$4.67M -68,778 Closed
Legal & General Group
54
Legal & General Group
United Kingdom
– -$4.11M -60,658 Closed
California Public Employees Retirement System
55
California Public Employees Retirement System
California
– -$4M -58,998 Closed
Allianz Asset Management
56
Allianz Asset Management
Germany
– -$3.9M -57,540 Closed
Public Sector Pension Investment Board (PSP Investments)
57
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
– -$3.72M -54,912 Closed
PAM
58
Panagora Asset Management
Massachusetts
– -$3.52M -51,966 Closed
Deutsche Bank
59
Deutsche Bank
Germany
– -$3.35M -49,404 Closed
Swiss National Bank
60
Swiss National Bank
Switzerland
– -$3.31M -48,800 Closed
Squarepoint
61
Squarepoint
New York
– -$3.3M -48,700 Closed
QI
62
QS Investors
New York
– -$3.08M -45,400 Closed
HIM
63
Hillsdale Investment Management
Ontario, Canada
– -$2.86M -42,110 Closed
California State Teachers Retirement System (CalSTRS)
64
California State Teachers Retirement System (CalSTRS)
California
– -$2.85M -41,980 Closed
State of New Jersey Common Pension Fund D
65
State of New Jersey Common Pension Fund D
New Jersey
– -$2.77M -40,800 Closed
AQR Capital Management
66
AQR Capital Management
Connecticut
– -$2.77M -40,797 Closed
CL
67
CSS LLC
Illinois
– -$2.76M -40,681 Closed
Susquehanna International Group
68
Susquehanna International Group
Pennsylvania
– -$2.75M -40,472 Closed
SG Americas Securities
69
SG Americas Securities
New York
– -$2.71M -39,889 Closed
SEI Investments
70
SEI Investments
Pennsylvania
– -$2.64M -39,380 Closed
GAM
71
Gotham Asset Management
New York
– -$2.62M -38,687 Closed
GCIA
72
Gabelli & Co Investment Advisers
New York
– -$2.58M -38,100 Closed
Macquarie Group
73
Macquarie Group
Australia
– -$2.58M -38,000 Closed
AG
74
AlphaSimPlex Group
Massachusetts
– -$2.55M -37,537 Closed
Prudential Financial
75
Prudential Financial
New Jersey
– -$2.45M -36,191 Closed
1 2
3
4 5

GHDX Hedge Fund Activity: Q4 2019 in Review

0 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q4 2019, worth a combined $0 — down 100% from $2.44B a quarter earlier.

Sellers outnumbered buyers: 219 funds closed out of GHDX and 0 opened new positions — a net loss of 219 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $627M sold.

  • 0 institutional investors held Genomic Health, Inc. (GHDX) as of Q4 2019, down from 221 in Q3 2019.
  • Funds reported $0 of Genomic Health, Inc. stock for Q4 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Genomic Health, Inc. positions in Q4 2019 and 219 closed out, a net change of -219 holders.
  • The largest Genomic Health, Inc. seller in Q4 2019 was Baker Bros. Advisors, an estimated $627M sold.

Based on aggregated 13F filings for Q4 2019.